1-Dehydro-6-gingerdione

CAS No. 76060-35-0

1-Dehydro-6-gingerdione( —— )

Catalog No. M31246 CAS No. 76060-35-0

1-Dehydro-6-gingerdione is a 5-HT1A receptor partial agonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 353 In Stock
10MG 521 In Stock
25MG 826 In Stock
50MG 1088 In Stock
100MG 1460 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    1-Dehydro-6-gingerdione
  • Note
    Research use only, not for human use.
  • Brief Description
    1-Dehydro-6-gingerdione is a 5-HT1A receptor partial agonist.
  • Description
    1-Dehydro-6-gingerdione is a 5-HT1A receptor partial agonist.
  • In Vitro
    6-Dehydrogingerdione could trigger apoptotic cell death via both mitochondrial- and Fas receptor-mediated pathways.6-Dehydrogingerdione (6-DG) up-regulates Ser-15 phosphorylation and evoked p53 nuclear translocation.6-Dehydrogingerdione (6-DG) induces mitochondrial apoptotic pathway. Apoptosis Analysis Cell Line:Hep G2 cells.Concentration:0, 50, 100 μM.Incubation Time:24 h.Result:Induced Apoptosis in Hep G2 Cells.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    76060-35-0
  • Formula Weight
    290.4
  • Molecular Formula
    C17H22O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • 2-Butyloctanoic acid

    2-Butyloctanoic acid can be used in the skin care industry.

  • MitoBloCK-11?(MB-11)

    MitoBloCK-11 (MB-11) is a s mall molecule inhibitor of mitochondrial protein import possibly acts through transport protein Seo1, but not Tom70 or Tom20;?inhibits precursor proteins that contain hydrophobic segments, confers growth in media lacking uracil in a specific manner and affects zebrafish development.

  • Vazegepant HCl

    Vazegepant is the first intranasal gepant for the acute treatment of migraine and has announced a positive phase II/III study.